Cassava Sciences outlines Pivotal Phase 3 trial design for Simufilam in Alzheimer’s
February 22 2021 - 11:49AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From Sep 2023 to Sep 2024